phloroglucinol has been researched along with Cardiovascular Stroke in 2 studies
Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.
phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, C | 1 |
| Li, W | 1 |
| Wang, X | 1 |
| Xue, J | 1 |
| Zhao, L | 1 |
| Song, Y | 1 |
| Zhou, T | 1 |
| Zhang, M | 1 |
| Li, TT | 1 |
| Zhang, YS | 1 |
| He, L | 1 |
| Li, NS | 1 |
| Peng, J | 1 |
| Li, YJ | 1 |
2 other studies available for phloroglucinol and Cardiovascular Stroke
| Article | Year |
|---|---|
Phloroglucinol averts isoprenaline hydrochloride induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Biomarkers; Cardiotonic Agents; Electrocardiography; Heart; Isoproterenol; Li | 2019 |
Protective effect of phloroglucinol against myocardial ischaemia-reperfusion injury is related to inhibition of myeloperoxidase activity and inflammatory cell infiltration.
Topics: Animals; Apoptosis; Cardiotonic Agents; Drug Evaluation, Preclinical; Enzyme Inhibitors; Inflammatio | 2011 |